References
- Calaf I, Alsina J. Benefits of hormone replacement therapy – overview and update. Int J Fertil Womens Med 1997;42(Suppl 2): 329–46
- Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;288:321–33
- Schneider H. The view of The International Menopause Society on the Women's Health Initiative. Climacteric 2002;5:211–16
- Stevenson JC, Hodis HN, Pickar JH, Lobo RA. Coronary heart disease and menopause management: the swinging pendulum of HRT. Atherosclerosis 2009;207:336–40
- Panay N, Fenton A. Has the time for the definitive, randomized, placebo-controlled HRT trial arrived? Climacteric 2011;14: 195–6
- International Menopause Society Writing Group. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric 2011;14: 302–20
- The North American Menopause Society. Estrogen and progestogen use in postmenopausal women: 2012 Position Statement of The North American Menopause Society. Menopause 2012; 19:257–71